Director, Data and Science (Analytic Solutions)
Verana HealthSalary not specified
- Full Time
- Senior (5 to 8 years), Expert & Leadership (9+ years)
About Verana Health
Verana Health assembles and analyzes large-scale clinical databases to support physicians and enhance medical research. By partnering with medical associations, the company creates regulatory-grade data platforms that generate valuable medical evidence and insights. These platforms serve life science companies and healthcare providers, offering them data that improves evidence generation and patient outcomes. Verana Health focuses on big data, analytics, and artificial intelligence to provide actionable insights that help life science companies accelerate research, identify trial patients, and understand patient experiences better. The company earns revenue through partnerships and data services offered to its clients.
San Francisco, CaliforniaHeadquarters
2018Year Founded
$280.9MTotal Funding
SERIES_ECompany Stage
Data & Analytics, Biotechnology, HealthcareIndustries
51-200Employees
Benefits
Health Insurance
Dental Insurance
Vision Insurance
401(k) Company Match
Parental Leave
Unlimited Paid Time Off
Professional Development Budget
Mental Health Support
Risks
Competition from other digital health companies leveraging AI and big data analytics.
Rapid evolution of data privacy regulations may increase compliance costs.
Reliance on medical association partnerships could be a vulnerability if disrupted.
Differentiation
Verana Health manages data from over 20,000 providers and 70 EHR systems.
Their VeraQ™ engine enhances data integrity with AI and clinician direction.
Exclusive partnerships with specialty medical societies provide unique, regulatory-grade data platforms.
Upsides
Raised $150M in Series E funding, indicating strong investor confidence.
Acquisition of PYA Analytics enhances data processing and insights generation capabilities.
Focus on integrating unstructured data like physician notes increases data depth and usability.
Funding
Total raised$280.92 M
Latest valuation$750.00 M
StageSERIES_E
SERIES D
1/31/2020$100
$500.00 MSERIES C
6/30/2018$30
$150.00 MSERIES B
1/31/2015$8
$39.00 MSERIES A
12/31/2012$1
$5.00 M